the world's headlines, one feed
BioMarin drops rare disease asset after mixed Phase 3: BioMarin decided to discontinue development of BMN401, an enzyme replacement therapy for ENPP1 deficiency, the biotech said as part of its second-quarter ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Early respiratory infection burden is associated with atopic dermatitis (AD) diagnosis in childhood, according to a study published online July 29 in JAMA Dermatology.
A combination of omega-3 and low-dose acetylsalicylic acid (ASA) produced results comparable to antibiotics in treating severe periodontitis. This conclusion is based on a study conducted by researchers affiliated with Albert Einstein Israelite Hospital, Guarulhos University (UNG), the University of Taubaté (UNITAU), and the Ribeirão…
Jalapeño peppers linked to a multistate salmonella outbreak have been traced back to a grower in Sinaloa, Mexico, federal officials say.
China’s rapid advance in biotech will slow as companies there begin to experiment on the cutting edge of R&D, according to Pfizer’s Andrew Baum, who expects the risks of biology and drug development…
Health Secretary Robert F. Kennedy Jr. is visiting the Centers for Disease Control and Prevention campus as Dr. Erica Schwartz prepares to lead the nation's top federal health agencies. CBS News' Dr.
Cancer diagnostics breach spills personal and health info as extortion crew says healthcare giant ‘should’ve paid the ransom’